Learn More
The federal cases are
There are currently more than 150 product liability lawsuits and class action claims pending in the federal court system that have resulted in valsartan recalls issued
The levels of impurities were trace amounts, but that was still deemed unacceptable
In this issue of the Legal Look, we are covering a would-be Roundup class action lawsuit in Wisconsin that was denied certification, the expansion of recalls over
Our law firm is no longer accepting Losartan cases
has recalled 87 lots of Losartan medications because it may contain a cancer-causing impurity
Past client? Leave a review
S
Losartan Cancer Lawsuit No
Some of the drugs involved included Actonel, Alorvad, Benoxyl, Boniva, Biaxin, Biron, Brackcia Losartan blocks angiotensin, relaxes blood vessels, and reduces the risks it poses
Lawyers for consumers who claim harm from tainted versions of the blood pressure-lowering drug valsartan want to expand This proposed class action arises out of concerns for Irbesartan, Losartan and Valsartan medications (“Sartans”), all of which are angiotensin receptor blockers, which are a class of drugs used to treat patients with high blood pressure to help prevent heart attacks and stroke
The creation of an MDL is the first step in the litigation process that starts the settlement Lori May 25, 2022 at 10:02 am
The Diovan class action lawsuit MDL in New Jersey has only added 120 new cases in the past six months towards the end of October 2022
CAMDEN, N
District Court for the District of New The FDA said in the recall announcement anyone taking losartan should continue using it until you have spoken with a physician, as the risk may be higher if stopped abruptly
Renée Marie Bumb, Chief Judge | Melissa E
I don't have a Class Member ID or know my NDC code (s), but I purchased/consumed a generic Valsartan drug
Its a class action not hoir average car wcvident lawyers in state court
Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and Merck Pays $688 Million for Vytorin (2013) Merck’s shareholders filed two class action lawsuits against headquarters when it was revealed that the company concealed the poor results of Vytorin, a rival anti-cholesterol drug, in its clinical trial
If you had cancer, liver damage, or side effects of Irbesartan, contact our lawyers for lawsuit info at (866) 920-0753